Real world experience with pegylated interferon and ribavirin in hepatitis C genotype 1 population with favourable IL28B polymorphism

Background and aim: Conventional hepatitis C treatment using pegylated interferon (PEG-IFN) and ribavirin is associated with significant side effects. IL28B polymorphism can predict response to treatment, with CC genotype having a better response. ITPA gene deficiency protects against clinically sig...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Gastroenterol Rep (Oxf)
Main Authors: Ekstrom, Victoria, Kumar, Rajneesh, Zhao, Yi, Yee, Mei Ling, Sung, Cynthia, Toh, Dorothy, Loh, Poh Yen, Tan, Jessica, Teo, Eng Kiong, Chow, Wan Cheng
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5554392/
https://ncbi.nlm.nih.gov/pubmed/28852525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/gastro/gow033
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados